viewFevertree Drinks PLC

Fever-Tree to be "materially ahead" of market expectations

The fizzy drink maker anticipates full year results to smash market expectations after strong start to 2016

Selection of Fever-Tree bottles
Fever-Tree offers a range of fizzy drinks, including five types of tonic water

Shares in the soft drinks manufacturer Fevertree Drinks PLC (LON:FEVR) fizzed higher as it indicated it will massively  outperform market expectations in 2016.

The firm has said the positive forecast is down to “strong sales” at the beginning of the year.

“The board anticipates that the results for the full year ending 31 December 2016 will be materially of ahead of market expectations,” said Fever-Tree.

Investec says it expects the soft drinks company’s full year revenue to rise to £78.7mln, a 33% increase on 2015,

It also predicts that underlying profits will increase to £24.9mln in 2016, a year-on-year rise of 37%.

The broker reiterated its ‘Buy’ recommendation.

Shares were up 65.5p or 11% to 663.5p.

Quick facts: Fevertree Drinks PLC

Price: 2126 GBX

Market: AIM
Market Cap: £2.47 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Summit Therapeutics' Glyn Edwards talks US$50mln backing and ridinilazole...

Summit Therapeutics PLC's (LON:SUMM, NASDAQ:SMMT) CEO Glyn Edwards sat down with Proactive London's Andrew Scott following the news of a US$50mln funding deal with biotech billionaire Bob Duggan. The investment will help get the company’s next-generation antibiotic through phase III clinical...

8 hours, 36 minutes ago


Director Disclosure

1 week, 4 days ago

Trading Update

2 weeks, 6 days ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Interim Results

on 23/7/19

2 min read